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The C protein of measles virus (MV C) is a basic protein of 186 amino acids (aa) that plays at least two roles in infected cells, interference
with the innate immune response and modulation of viral polymerase activity. In this study, Northern blots were used to demonstrate that C
proteins from three vaccine strains and three wild-type isolates of MV downregulated both mRNA transcription and genome replication in a
plasmid-based mini-genome assay. The effect on transcription always paralleled the effect on replication; however, the six MV C proteins
varied considerably in their ability to inhibit polymerase activity. Though the amino-terminal 45 aa of the C protein are more variable among
different MV strains than the remaining 75% of the protein, the ability of the MV C proteins to inhibit polymerase activity was not regulated
by substitutions in the amino terminus, but rather by the more conserved region containing aa 46–167. Naturally occurring substitutions at
positions 147 and 166, but not 88 and 186, were found to regulate MV C protein activity. Deletion of the carboxyl-terminal 19 aa did not
affect the polymerase-modulating activity. Though we did not find a link between the aa changes in MV C and attenuation, these data provide
new information regarding the functions of this non-structural protein.
Published by Elsevier Inc.
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Measles infection is typified by conjunctivitis, high fever,
cough, coryza, and the appearance of a maculopapular rash.
Although a vaccine preventable disease, it still accounts for
approximately 700,000 deaths annually worldwide. Measles
virus (MV) is a member of the Morbillivirus genus of the
family Paramyxoviridae. The virions contain single-
stranded, negative-sense RNA genomes of 15,894 nucleo-
tides (nt), which are encapsidated by the viral nucleocapsid
protein (N). This nucleocapsid serves as the template for the
viral polymerase complex, which consists of the phospho-0042-6822/$ - see front matter. Published by Elsevier Inc.
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E-mail address: prota@cdc.gov (P.A. Rota).protein (P) and the polymerase or large protein (L)
(reviewed in Griffin, 2001). N, P, and L are the proteins
minimally required to reconstitute transcription and repli-
cation in experimental systems.
The MV C protein (MV C) was first described by Bellini
et al. (1985) as a small, non-structural protein of 186 amino
acids (aa) with an apparent molecular weight of 20 kDa.
MV C is very basic (pI = 10), and it can be detected both in
the cytoplasm and the nucleus of infected cells. Recently,
small amounts of MV C have been detected in preparations
of purified virions (Devaux and Cattaneo, 2004). The MV C
protein is translated from a reading frame overlapping the 5V
terminus of the P open reading frame. A comparison of
deduced amino acid sequences of MV C proteins from
vaccine and wild-type strains demonstrated considerable
variability in the amino-terminal 45 residues of the C05) 120–129
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more conserved (Baczko et al., 1992; Bankamp et al., 2002).
MV C interacts with the L protein (Reutter et al., 2001), a
characteristic MV shares with the closely related morbilli-
virus, rinderpest virus (RPV) and the respiroviruses, Sendai
virus (SeV) and human parainfluenza virus 3 (hPIV3)
(Horikami et al., 1997; Smallwood and Moyer, 2004;
Sweetman et al., 2001).
Two approaches that have been used to study the
functions of MV C are the characterization of a recombinant
MVengineered to be deficient in expression of the C protein
(MV C-) and in vitro assay systems using transiently
expressed C proteins. Experiments with the MV C- virus
demonstrated that the protein is expendable in several cell
lines of non-human origin, but growth of the MV C- virus
was impaired in human cell lines (Escoffier et al., 1999;
Radecke and Billeter, 1996). Growth in human cell lines
was restored following addition of antisera to interferon a/h
to the cultures (Shaffer et al., 2003). In small animal
models, MV C- showed reduced pathogenicity (Patterson et
al., 2000; Valsamakis et al., 1998). Experiments with
another recombinant MV with silenced C expression
demonstrated a possible role for MV C in particle assembly
(Devaux and Cattaneo, 2004). A recombinant RPV which
did not express a C protein was defective in growth in cell
culture (Baron and Barrett, 2000), while abrogation of
expression of all four C ORFs of SeV produced a barely
viable virus that was attenuated in mice (Kurotani et al.,
1998).
While it has proven difficult to analyze the role of the
MV C protein in the context of the whole virus, two distinct
functions have emerged from assay systems designed to
measure specific activities. The MV C protein interferes
with the cell’s ability to respond to interferon signaling,
thereby preventing the establishment of an antiviral state
(Shaffer et al., 2003). Together with the MV V protein, MV
C forms complexes with IFNAR I (type I interferon receptor
chain I), RACK I (receptor for activated C kinase h) and
STAT I (signal transducer and activator of transcription I)
which may interfere with the interferon signaling pathway
(Yokota et al., 2003). A second function of the MV C
protein is a downregulation of RNA synthesis, as measured
by reporter protein expression from mini-genome replica-
tion assays (Reutter et al., 2001). Both functions are similar
to those described for the C proteins of SeV (Curran et al.,
1992; Garcin et al., 2000; Kato et al., 2004; Tapparel et al.,
1997) and hPIV3 (Smallwood and Moyer, 2004). Recently,
the C protein of Nipah virus, a member of the genus
Henipavirus, has been shown to inhibit interferon signaling
(Park et al., 2003).
Live, attenuated MV vaccines provide safe and effective
prevention of disease. Some of the vaccine strains, for
example, Moraten and Edmonston-Zagreb were derived
from the prototype Edmonston wild-type isolate (Enders
and Peebles, 1954). The Cam-70 vaccine strain was
generated from the Tanabe wild-type virus (Okuno et al.,1971). All measles vaccine strains are members of genotype
A (Rota et al., 1994b). Although the complete genomic
sequences of several vaccine strains have been determined
(Parks et al., 2001a, 2001b), the genetic basis for attenuation
remains unknown.
Since our laboratory is studying the genetic differences
between vaccine and wild-type strains of MV, we cloned and
expressed the C proteins from three vaccine strains and three
wild-type viruses. Northern blot analysis was used to show
that MV C downregulated both mRNA transcription and
genome replication in a plasmid-based mini-genome repli-
cation assay. While C proteins from both vaccine and wild-
type MV strains were able to regulate polymerase activity,
the level of downregulation varied considerably. We further
demonstrate that the degree to which an MV C protein could
inhibit replication and transcription was affected by amino
acid substitutions between residues 46 and 167.Results
Transient expression of MV C proteins
The C ORFs of six MV strains were cloned into the
expression vector pTM1. These six strains included three
vaccine strains, Cam-70 (Cam), Moraten (Mor), and
Edmonston-Zagreb (Zag), as well as three cell culture-
adapted wild-type viruses, Edmonston wild-type (Edwt,
genotype A), Illinois-89 (Il-1, genotype D3), and Gambia-
91 (Gam, genotype B3). Sequence analysis of the cloned C
genes showed that, as reported previously (Baczko et al.,
1992; Bankamp et al., 2002), the amino-terminus (predicted
amino acid 1–45) is more variable than the remainder of the
protein (Table 1). Nine of 45 (20%) amino acid positions in
the amino-terminal domain are variable, but only nine of the
remaining 141 (6%) residues vary. When expressed in an in
vitro transcription/translation system, all six plasmids
expressed proteins of approximately 20 kDa that reacted
with antiserum to MV C protein (data not shown). We were
unable to detect the MV C proteins in transfected CV-1
cells. However, transient expression in B95a cells produced
faint but clearly visible bands in immunoprecipitation
experiments (Fig. 1A). All six MV C proteins were detected
after a 2-h pulse, but none were stable to an overnight chase.
These data suggest that the MV C protein has a relatively
high turnover rate and that the turnover rates vary in
different cell lines.
MV C protein inhibits transcription and replication in a
dose-dependent manner
Since it had been reported that MV C downregulates the
expression of reporter protein in a mini-genome replication
system (Reutter et al., 2001), we conducted experiments to
determine whether the presence of the MV C protein
affected transcription of the reporter gene, replication of the
Table 1




Zaga Mor Cam Edwt Il-1 Gam GaZa ZaGa
10 Gb Ec E
13 R K
15 S N
23 R K K
25 L P
35 T I I I
39 S T
44 G R R R
45 K R R
73 V A
78 R K




147 I T T
166 S P
186 S C C
a Strain names are abbreviated as Zag (Edmonston-Zagreb), Mor (Mor-
aten), Cam (Cam-70), Edwt (Edmonston wild-type), Il-1 (Illinois-89), Gam
(Gambia-91). The chimeras GaZa and ZaGa are described in the text.
b Single-letter amino acid code.
c Bold letters indicate nonconservative substitutions relative to Zag
sequence.
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their transfection efficiency and because a previous study
had shown that the interferon antagonist activity of MV C
was only detectable in human cell lines and not in CV-1
cells (Shaffer et al., 2003). Therefore, this simian cell line
was used in order to separate the interferon-modulating
effects of MV C from the effects on replication.Fig. 1. Expression of MV C proteins (panel A) and mutant MV C proteins (panel B
Proteins were 35S-methionine-labeled for 2 h (pulse, P), followed by a 15-h chase (
antiserum and separated by SDS-polyacrylamide gel electrophoresis. Molecular ma
the right. Vector: cells transfected with pTM1 as control. In panel B, all samples
deletion of carboxyl-terminal 19 amino acid, GaZa: chimeric C protein with aminoCV-1 cells were transfected with a MV mini-genome
expressing the chloramphenicol-acetyl-transferase (CAT)
protein, as well as with plasmids expressing the EdmBil
N, EdmBil P, and Cam L proteins. EdmBil genes correspond
to those in the infectious clone (Radecke et al., 1995).
Increasing amounts of pTM1-Cam C were co-transfected,
while the total amount of DNA was kept constant through
the addition of vector DNA. In these and all subsequent
experiments, two independent plasmid preparations of each
MV C clone were tested, to rule out effects due to the
quality of plasmid preparations or inaccuracies in measure-
ment of DNA concentrations. 42–48 h post-transfection,
poly A-selected mRNA was analyzed to measure levels of
transcription, while micrococcal nuclease-resistant genomic
RNA was used to measure replication. Northern blots were
hybridized with CAT gene-specific negative sense probes to
detect mRNA and positive sense probes to detect genomic
RNA. From the pMV107(-)CAT plasmid, T7 transcribes a
negative-sense mini-genome containing the reverse-comple-
ment of the CAT ORF. After encapsidation, MV replication
and/or transcription is initiated at the genomic leader.
Generation of polyA+ CAT mRNA requires transcription
of the negative-sense mini-genome. The positive-sense
probe used to detect micrococcal nuclease-resistant repli-
cation products should also detect the encapsidated T7
transcript, however, the assay is not sensitive enough to pick
up the relatively small amount of T7 transcript (see Fig. 2B,
lanes bno LQ). Co-transfection of increasing amounts of Cam
C plasmid leads to decreasing levels of both CAT mRNA
and minigenome negative sense RNA (Fig. 2). These data
demonstrated that co-expression of MV C leads to a dose-
dependent inhibition of both reporter gene transcription and
mini-genome replication.). MVAT7-infected B95a cells were transfected with the indicated plasmid.
C). MV C proteins were immunoprecipitated with a C protein-specific rabbit
ss markers are shown on the left; the positions of C proteins are indicated on
were processed simultaneously, and then separated on two gels. ZagCstop:
acid 1–45 of Gam C, 46–186 of Zag C. ZaGa: converse chimera to GaZa.
Fig. 2. MV C protein inhibits transcription and replication in a dose-
dependent manner. MVAT7-infected CV-1 cells were transfected with
pTM1-EdmBil N, pTM1-EdmBil P, pTM1-Cam L, pMV107(-)CAT, and
the indicated amounts of pTM1-Cam C. Duplicate transfections are shown
for each amount of MV C plasmid. In the negative controls, pTM1-Cam L
was omitted. The amount of transfected DNAwas kept constant through the
addition of pTM1 vector. RNA was separated on formaldehyde-agarose
gels, transferred to nylon membrane, and hybridized with digoxigenin-
labeled, CAT gene-specific RNA probes. The chemiluminescent signal was
detected by autoradiography. Panel A shows poly (A)+ selected RNA
hybridized to a negative sense probe. Panel B shows micrococcal nuclease-
resistant RNA hybridized to a positive sense probe. For each panel, the
results of one representative experiment out of three independent experi-
ments are shown. The positions of mRNA and genomic RNA are indicated
on the right.
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strains
In an attempt to define genetic differences between
vaccine and wild-type strains, we compared the ability of six
MV C proteins to inhibit transcription and replication in the
mini-genome replication assay. 1 Ag pTM1-C was chosen
for this and all subsequent experiments. The levels of RNA
synthesis in the presence of these six MV C proteins varied
considerably (Fig. 3). The MV C proteins derived from the
vaccine strains Cam, Mor, and Zag were more active in
inhibiting transcription and replication than the MV C
proteins derived from the wild-type isolates Il-1 and Gam;
however, the C protein from Edwt was as active as the
vaccine C proteins. For each MV C protein, the level ofFig. 3. C proteins of different MV strains inhibit transcription and replication to var
in the legend to Fig. 2, except that 1 Ag of each pTM1-C plasmid was transfected.
poly (A)+ selected RNA hybridized to a negative sense probe. Panel B shows mi
each panel, the results of one representative experiment out of three independen
indicated on the right.inhibition of transcription corresponded to the effect on
replication.
Activity of MV C proteins upon co-expression with
homologous or heterologous N, P, and L proteins
The experiments described above had been carried out
with the L protein from Cam and the N and P proteins from
EdmBil. The N and P genes were derived from the
infectious clone of MV (Radecke et al., 1995), which is
based on a cell-culture adapted, attenuated Edmonston
strain. Previous work had demonstrated that the L protein
of Cam produced the greatest amount of CAT reporter
protein in a mini-genome replication assay when compared
to a group of five L proteins from different strains of MV.
The relative levels of activity of the various L proteins were
not affected by the presence of homologous or heterologous
N and P proteins (Bankamp et al., 2002).
We wished to examine whether the ability of MV C to
inhibit replication and transcription was affected by the
source of N, P and L proteins in the replication assay. To this
end, the C proteins of Cam, Gam, and Il-1 were co-
expressed with homologous or heterologous N, P, and L
proteins. Since a cloned copy of the Cam N gene was not
available, EdmBil N was used. There is only one
conservative amino acid difference between Cam N and
EdmBil N at residue 434, which is Ala in Cam N and Gly in
EdmBil N (GenBank accession numbers U03650, Z66517).
The production of CAT reporter protein was measured by
ELISA (Fig. 4). Regardless of the source of the N, P, and L
proteins, the Cam C protein demonstrated the highest level
of inhibition of reporter protein expression while the Gam C
protein was the least active in these assays (Fig. 4). Even
when co-expressed with their homologous N, P, and L
proteins, the C proteins of Il-1 and Gam remained less active
than the Cam C protein. These results showed that the
differential ability of the C proteins to inhibit replication and
transcription is a function of the C protein itself. It should be
noted that the relative levels of CAT protein expressed in theying degrees. Transfections and Northern blots were performed as described
Duplicate transfections are shown for each MV C plasmid. Panel A shows
crococcal nuclease-resistant RNA hybridized to a positive sense probe. For
t experiments are shown. The positions of mRNA and genomic RNA are
Fig. 4. Ability of MV C proteins to inhibit reporter gene expression when co-expressed with homologous or heterologous N, P, and L proteins. MVAT7-infected
CV-1 cells were transfected with pMV107(-)CAT and (panel A) pTM1-EdmBil N, pTM1-Cam P, pTM1-Cam L; (panel B) pTM1-Gam N, pTM1-Gam P,
pTM1-Gam L; (panel C) pTM1-Il-1 N, pTM1-Il-1 P, pTM1-Il-1 L, and 1 Ag of the indicated pTM1-C plasmids. In the negative controls, the L plasmid was
omitted. The amount of transfected DNA was kept constant through the addition of pTM1 vector. CAT protein concentration in cytoplasmic extracts of
quadruplicate samples was measured by ELISA. The amount of CAT protein produced in the absence of a C protein was set to 100% in each panel. For each
panel, the results of one representative experiment out of three independent experiments are shown. Error bars denote one standard deviation.
Fig. 5. Activity of chimeric C proteins and the deletion mutant. Panel A:
MVAT7-infected CV-1 cells were transfected with pTM1-EdmBil N,
pTM1-EdmBil P, pTM1-Cam L, pMV107(-)CAT, and 1 Ag of the indicated
pTM1-C plasmids. Transfections and ELISA were performed as described
in the legend to Fig. 4. Panel B shows the positions of amino acid
substitutions in Gam C and the chimeras relative to Zag C.
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ments incorporating the N, P, and L proteins of the Il-1 virus
(Fig. 4C), suggesting that the L protein of Il-1 may be less
sensitive to inhibition by the C protein.
Activity of chimeric C proteins and a carboxyl-terminal
deletion mutant
In order to analyze the contribution of the variable amino
terminus to the ability of MV C to inhibit transcription and
replication, chimeric C proteins were constructed containing
regions of Gam C, which exhibited a low level of inhibition,
and Zag C, which demonstrated a high level of inhibitory
activity. The GaZa chimeric C protein contained the Gam C
amino terminus, while the remainder of the protein was
derived from Zag C (Table 1 and Fig. 5B). The ZaGa
chimera was the converse of GaZa. Amino acids 46–87 are
identical in both Gam C and Zag C. Takeuchi et al. (2000)
described a Vero cell-adapted wild-type MV isolate that
expressed a truncated C protein. The authors speculated that
this mutation played a role in adaptation to Vero cells. To
examine whether the carboxyl terminal deletion interfered
with the functionality of the C protein, a stop codon was
introduced at the same amino acid position (amino acid 168)
in the Zag C protein, truncating expression of the carboxyl-
terminal 19 amino acid. The resulting protein was called
ZagCstop. Expression of these three mutant C proteins was
demonstrated in Fig. 1B. The ZaGa C protein weakly
inhibited CAT production and was similar in activity to the
Gam C protein, while the GaZa C protein was as effective at
inhibition as the Zag C protein (Fig. 5). These results
indicated that the level of inhibitory activity was not
regulated by the variable amino terminus, but rather by
the relatively conserved remainder of the protein. The
ZagCstop mutant remained very active in the inhibition ofCAT reporter protein production (Fig. 5), demonstrating that
the last 19 amino acids of the C protein are not required for
regulation of RNA synthesis.
Activity of point mutants
A comparison of the relatively conserved part of the C
protein (amino acids 46–186) revealed five amino acid
substitutions between the highly active Zag C and the less
active Il-1 and Gam C proteins. Zag C and Il-1 C differ at
amino acids 78 and 166, while Zag C and Gam C differ at
B. Bankamp et al. / Virology 336 (2005) 120–129 125amino acids 88, 147, and 186 (Table 1).We introduced four of
these amino acid substitutions into Zag C, generating clones
that expressed mutant C proteins, ZagS88P, ZagI147T,
ZagS166P, and ZagS186C (Fig 1B). Analysis of reporter
protein production demonstrated that the amino acid changes
at positions 88 and 186 did not affect the inhibitory activity of
the mutant C proteins relative to that of the Zag C protein.
However, the amino acid changes at positions 147 and 166
reduced the ability of the mutants to inhibit reporter protein
production to levels comparable to those of the wild-type Il-1
C and Gam C proteins (Fig. 6). These results showed that
naturally occurring amino acid variations in the carboxyl-
terminal domain of the MV C protein affect its ability to
regulate RNA synthesis.Discussion
The C protein of MV is an accessory protein that
modulates viral genome replication. Recent studies have
shown that the MV C protein inhibits expression of a
reporter protein in a plasmid based mini-genome replication
assay (Reutter et al., 2001). That study did not distinguish
between inhibition of viral transcription and replication.
Data presented in this report demonstrated that C proteins
from six MV strains inhibited viral genome replication in a
mini-genome assay and that the inhibitory effect on
replication was paralleled by an equivalent effect on
transcription. At this time, we cannot distinguish between
a direct inhibition of transcription itself and reduced
transcription as a consequence of reduced amounts of
available template. It has been shown that in the absence
of a functional antigenomic promoter, and therefore in the
absence of replication, expression of reporter protein from
the MV mini-genome was undetectable, suggesting that the
majority of transcripts were generated from amplified
template (Walpita, 2004). However, it is also possible that
MV C interferes with a mechanism common to bothFig. 6. Activity of point mutants. MVAT7-infected CV-1 cells were transfected wi
1 Ag of the indicated pTM1-C plasmids. Transfections and ELISA were performetranscription and replication, such as initiation or elonga-
tion. The C proteins of the respiroviruses, SeV and hPIV3,
have been shown to specifically inhibit transcription (Curran
et al., 1992; Grogan and Moyer, 2001; Smallwood and
Moyer, 2004). In this report, we also showed that the ability
to regulate RNA synthesis is an intrinsic property of MV C
and not affected by natural genetic variation in the proteins
of the polymerase complex. In this regard, the MV C
proteins are similar to the MV L proteins, which have
intrinsically different levels of replication activity in
minigenome assays, and these levels are unaffected by the
presence of heterologous or homologous N and P proteins
(Bankamp et al., 2002).
The molecular basis for the attenuation of MV remains
undefined. All three vaccine C proteins strongly inhibited
transcription and replication, while two of the three wild-
type C proteins demonstrated reduced activity. The third
wild-type C protein, Edwt C, inhibited RNA synthesis to a
degree similar to that observed for the C proteins from
vaccine strains. While these data show that the C proteins
from some strains of MV are more efficient at down-
regulating RNA synthesis than others, they do not provide a
clear indication how genetic variation in MV C might
contribute to attenuation.
Comparison of the predicted amino acid sequences of
27 MV C proteins showed that the amino terminal 45
positions are much more variable than the remainder of the
protein (data not shown) and this observation is consistent
with information previously reported for MV C and SeV C
(Baczko et al., 1992; Fujii et al., 2001). The data obtained
with the chimeric MV C proteins demonstrate that the
ability to regulate RNA synthesis is not affected by
substitutions in the amino-terminal domain, but rather by
the relatively conserved residues at positions 46–186. Site-
directed mutations in MV C indicated that amino acids 147
and 166, but not amino acids 88 and 186, affected the
ability of the C protein to downregulate transcription and
replication.th pTM1-EdmBil N, pTM1-EdmBil P, pTM1-Cam L, pMV107(-)CAT, and
d as described in the legend to Fig. 4.
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isolate of MV following passage in either B95a cells or Vero
cells showed that the Vero-passaged strain had an amino
acid substitution in the matrix protein and a mutation in the
P/V/C gene that introduced a stop codon in the C ORF at
residue 168, truncating the carboxyl-terminal 19 amino
acids (Takeuchi et al., 2000). Here, we show that truncation
of the carboxyl-terminal 19 amino acids of Zag C did not
diminish its ability to downregulate CAT protein production.
The data obtained with the deletion mutant were supported
by the observation that a non-conservative amino change
from Ser to Cys at the carboxyl terminal residue (position
186) did not affect MV C activity. It is interesting to note
that the B95a-passaged MV isolate retained pathogenicity in
cynomolgus macaques, while the Vero-adapted virus had
lost its pathogenicity (Takeuchi et al., 2000). Therefore, it is
possible that even though truncation did not affect the
ability of MV C to regulate RNA synthesis, other functions
of the C protein, such as the ability to serve as an antagonist
of the interferon response, may be affected. It should be
noted that most Vero cell-adapted strains of MV, including
Gam and Il-1, do not have a truncated C protein. Kato et al.
reported that a 14-amino acid carboxyl-terminal deletion of
the SeV C protein abrogated downregulation of RNA
synthesis (Kato et al., 2002). While the functions of the
MV and SeV C proteins appear to be similar, there is no
sequence homology between these proteins and it is likely
that functional domains are located in different parts of the
proteins.
There is no correlation between the amino acid sub-
stitutions in MV C that affect regulation of replication and
transcription with corresponding amino acids changes in the
P protein. The nucleotide substitutions that predict amino
acid changes at positions 147 and 186 of MV C are silent in
the P reading frame. The nucleotide changes that cause the
substitutions at amino acid 88 (Gam C) and 166 (Il-1 C) also
change amino acid 95 and 173 in the respective P ORFs
relative to Zag P, in both cases from Ile to Thr. It is
interesting that a substitution at amino acid 166 affected the
activity of the Zag C protein, while the introduction of a
stop codon at position 168 had no effect. It appears that the
functional domain required for downregulation of RNA
synthesis extends to the point where the truncation occurred.
Taken together, these results indicate that the ability of MV
C to affect RNA synthesis is regulated by amino acids
46–167, while the carboxyl terminus is dispensable for this
function. MV C binds the L protein (Smallwood and Moyer,
2004), and for the SeV C protein, it has been shown that
C–L interactions are required for the inhibitory effect on
RNA synthesis (Grogan and Moyer, 2001). It is conceivable
that the amino acid substitutions in the Il-1 and Gam C
proteins affect the strength of the C–L interactions. Our
results show that MV C is unstable in transfected cells. To
our knowledge, there are no data available on the stability of
MV C in MV infected cells. There is less MV C detectable
in lytically infected cells than in persistently infected cells,but the protein is detectable both early (6 h) and late (24–36
h) post-infection (Bellini et al., 1985). It is possible that in
the context of an MV infection, MV C is stabilized by
interaction with other proteins, particularly the polymerase
protein.
Another function of the MV C protein is interference
with the cell’s ability to respond to interferon stimulation
(Shaffer et al., 2003). Together with the MV V protein, the
C protein forms complexes with IFNAR I, RACK I, and
STAT I, which may interrupt the interferon signaling
pathway (Yokota et al., 2003). This role of MV C is similar
to that of the SeV C proteins, whose interactions with the
interferon-signaling pathway have been examined in detail
(Garcin et al., 1999, 2003; Gotoh et al., 1999; Kato et al.,
2001; Komatsu et al., 2004). The C protein of Nipah virus, a
member of the genus Henipavirus, has also been shown to
antagonize the interferon system (Park et al., 2003). It is
unclear whether modulation of polymerase activity and
interferon-antagonism are related functions in MV.
Charge-to-alanine mutations in the SeV C protein greatly
reduced polymerase-modulating activity while retaining
interferon–antagonist activity, indicating that different
amino acids are involved in the two functions (Kato et
al., 2004). The abilities of the MV C proteins described in
this study to interfere with interferon signaling are being
evaluated.
Though it is still unclear if the C protein plays a role in
the attenuation of MV, we have presented new data that
further our understanding of the role that MV C plays in
regulating RNA synthesis. In vitro replication systems
mimic the late stage of MV replication, when all proteins
involved in RNA synthesis are present in abundance. Since
the C protein is translated from the second-most frequently
transcribed gene in the genome and the L protein from the
least frequently transcribed gene, it is possible that in the
infected cell the ratio of C/L may increase during the course
of infection. Such an excess of MV C relative to the amount
of MV L protein may lead to decreasing replication towards
the end of the replication cycle to allow for maturation of
virus particles. However, the ratios of C/L and the exact
mechanisms that regulate RNA synthesis of paramyxovi-
ruses are not known and it is difficult to predict how
changes in the ability of the C proteins to regulate RNA
synthesis might affect the pathogenicity of the virus. Studies
on the role of MV C in replication will need to be expanded
to include minimally passaged wild-type viruses with
defined levels of pathogenicity in experimental systems.Materials and methods
Cells and viruses
Vero cells, CV-1 cells, B95a cells, and primary chicken
embryo fibroblasts were maintained in Dulbecco’s modified
Eagle’s medium supplemented with 10% fetal calf serum,
B. Bankamp et al. / Virology 336 (2005) 120–129 127glutamine, and antibiotics. The origin and passage history of
MVi/Chicago.USA/89/1 (Il-1) (Rota et al., 1992) and
Edmonston wild-type (Edwt) (Rota et al., 1994a) have been
described previously. MVi/Banjul.GAM/91/1086 (Gam) was
isolated from human PBMC provided by H. Whittle,
Medical Research Laboratories, Gambia. The Kitasato sub-
master seed of the CAM-70 strain (Cam) was provided by I.
Yoshida, Kanonji Institute, Osaka, Japan. The Moraten strain
(Mor) was obtained from Merck, Sharp and Dohme. The
Edmonston-Zagreb strain (Zag) was provided by D. Ikic,
Institute of Immunology, Zagreb, Croatia. All virus strains
were propagated in Vero cells. The MVAT7 recombinant
vaccinia virus, which expresses the T7 polymerase, was
provided by B. Moss, Bethesda, MD, USA and was
propagated in primary chicken embryo fibroblasts.
RNA preparation, reverse transcription (RT)-PCR and
sequencing
Total cellular RNAwas extracted from MV-infected Vero
cells by the guanidinium-acid-phenol method (Chomczynski
and Sacchi, 1987). Reverse transcriptase reactions were
performed with an oligo (dT) primer and Superscript II
reverse transcriptase (Life Technologies) according to
manufacturer’s recommendations. PCR was performed with
the Elongase enzyme mix (Invitrogen). The C open reading
frames of Cam, Mor, Zag, Gam, Il-1, and Edwt were
amplified with specific primers from the same RNA prepara-
tion used to clone the respective N, P and L genes (Bankamp
et al., 1999, 2002). The C-specific primers were 5V -gatc-
gaattcccaggcacgccatgtca-3V (primer 1) and 5V -gatcctcgag-
GCTGTAGCTACTTCAT-3V (primer 2). Upper-case
nucleotides denote MV sequences. The EcoRI and XhoI
restriction sites, which were used to insert the C genes into
pTM1, are underlined. Primer 2 binds at the end of the P
ORF; therefore the entire rest of the P coding sequence is
included, even though it is not translated. PCR fragments
were sequenced using the ABI PRISM Dye Terminator
reaction kit (Perkin-Elmer) according to manufacturer’s
instructions with sequencing primers based on the EdmBil
sequence (GenBank accession number Z66517) (Radecke et
al., 1995). Sequence data were analyzed with the Sequencher
program (Gene Codes Corporation) and version 10.0 of the
sequence analysis software package of the University of
Wisconsin Genetics Computer Group (Devereux et al.,
1984). For the analysis of conservative amino acid changes,
amino acid were grouped into families as follows: (Phe, Tyr),
(Met, Leu, Ile, Val), (Ala, Gly), (Thr, Ser), (Gln, Asn), (Glu,
Asp), (Lys, Arg), (His), (Pro), (Trp), (Cys).
Construction of plasmids
All C genes were cloned into the same expression vector
with identical cloning strategies and 5V non-coding regions.
A stop codon was introduced at amino acid 168 of the Zag
C clone by mutating nt 504 of the C ORF from G to A(TGG = Trp, TGA = opal) using the Excite Mutagenesis kit
(Stratagene). A second, in frame stop codon was introduced
by mutating nt 509 from C to G (TCA = Ser, TGA = opal).
To create the ZaGa chimera, primer 1 and primer 3 (5V -
CGCGGATGCGAGGTGCACCG-3V ) were used to amplify
nt 1–216 of the Zag C ORF and primer 4 (5V -AGAAGG-
CAGGCAGTTCGGGTC-3V ) and primer 2 were used to
amplify nt 135 to the end of the P ORF. A mixture of these
overlapping DNA fragments then served as a template to
amplify the entire chimeric C ORF with primers 1 and 4.
The overlapping portion of the DNA fragments covers
amino acid 46–72, which are identical in both proteins. The
same strategy was employed to generate the GaZa chimera.
Construction of the N, P, and L plasmids used in this study
was described previously (Bankamp et al., 1999, 2002).
pMV107(-)CAT (Sidhu et al., 1995) was a gift of M. Billeter
(Zqrich, Switzerland). It contains 107 nucleotides of the MV
genomic 3V end and 109 nucleotides of the genomic 5V end
flanking the open reading frame of the CAT gene in a
bluescript vector. The DNA concentrations of CsCl-purified
plasmid preparations were determined using the fluoro-
chrome Hoechst 33258 (Gallagher, 1996). Fluorescence was
measured in a Spectrafluor fluorometer (Tecan).
Protein expression
B95a cells in 35-mm dishes were infected with MVAT7
at a multiplicity of infection (moi) of 5 and transfected 45
min later. 4 Ag plasmid DNA in Opti-MEM medium (Life
Technologies) were transfected with Lipofectamine 2000
(Invitrogen) following the manufacturer’s recommenda-
tions. Cells were labeled from 6 to 8 h after transfection
with 35S-methionine in methionine-free medium (ICN) and
then either lysed (pulse) or washed twice with DMEM
+10% FBS and incubated overnight in the same medium
(chase). Cytoplasmic cell extracts were prepared in NET-
BSA buffer (150 mM NaCl, 5 mM EDTA, 50 mM Tris–
HCl, 0.5% NP-40, 1 mg/ml BSA, pH 7.4). Aliquots of cell
extracts were incubated with a C-specific rabbit antiserum
followed by precipitation with GammaBind G-Sepharose
(Amersham Pharmacia Biotech). The complexes were
washed with NET-BSA and separated on a 4–20% gradient
SDS-polyacrylamide gel. After electrophoresis, bands were
visualized by autoradiography.
Replication assay
CV-1 cells in 35-mm dishes were infected with MVAT7
at an moi of 5 and transfected 45 min later. A mixture of
pTM1-N (1.55 Ag), pTM1-P (0.45 Ag), pTM1-L (0.40 Ag),
and pMV107(-)CAT (3.30 Ag) in Opti-MEM medium (Life
Technologies) was transfected with Cellfectin (Invitrogen)
following the manufacturer’s recommendations. In negative
controls, the L plasmid was replaced with pTM1. For every
C clone, two plasmid preparations were used, and for every
sample, transfection mixtures were set up in duplicate.
B. Bankamp et al. / Virology 336 (2005) 120–129128Every experiment was carried out at least three times. For
RNA analysis, 10 Ag Actinomycin D (Actinomycin
D-Mannitol, Sigma) per ml medium were added to the
medium 28 h after transfection.
CAT ELISA
Cytoplasmic extracts were prepared 42–48 h after
transfection in 500 Al of lysis buffer (part of the CAT
ELISA kit; Roche). Total protein concentration of the
extracts was measured with the BCL kit (Pierce), using
the microwell plate protocol, and optical densities were
determined at 562 nm in a Rainbow ELISA reader
(Tecan). The concentration of CAT protein in the extracts
was measured with the CAT ELISA kit (Roche) and
optical densities were determined in the Rainbow ELISA
reader at 405 nm. The amounts of extracts used per
sample were adjusted for protein concentration to ensure
comparable results.
Northern blot analysis
RNA was purified 42–48 h after transfection. Poly A+
RNA was isolated directly from cell lysates by use of
Oligotex particles and buffers (Qiagen), according to the
manufacturer’s recommendations for direct purification
from cultured cells. The protocol was modified for batch
procedure and followed by ethanol precipitation. For the
analysis of mini-genome replication, cytoplasmic extracts
were treated with micrococcal nuclease (S7 nuclease;
Roche) (Fearns et al., 1997). In brief, cells were lysed in
200 Al MN buffer (10 mM Tris–HCl, pH 7.5, 0.5% sodium
deoxycholate, 1% Triton X-100, 10 mM NaCl, 1.5 mM
MgCl2, 10 mM CaCl2, 9 K.I.U. aprotinin/ml [Roche], 200
U micrococcal nuclease/ml). Incubation of the lysate at 30
EC for 30 min was followed by RNA extraction with
Trizol LS (Life Technologies) according to manufacturer’s
recommendations.
RNA extracted from two-fifths of a 35-mm dish was
separated by electrophoresis on a 1.5% agarose gel
containing 3.7% formaldehyde, transferred to a nylon
membrane (Roche) by vacuum blotting (BioRad), and fixed
by UV cross-linking (Stratagene). Templates for in vitro
transcription of digoxigenin-labeled riboprobes correspond-
ing to 380 bases of the CAT gene were generated by PCR,
with primers incorporating the T7 promoter to generate
positive- or negative-sense probes. In vitro transcription of
the probes, hybridization, and detection of the bands was
carried out using the DIG system (Roche). Signals were
visualized by autoradiography.Acknowledgment
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